Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Pricing
Data Tools
Innovation Services
About Index
Index
By TNW
Log in
Register
NovImmune
210
NovImmune
Technology
Biotechnology
NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Suggest edits
Founded
1998
Raised
$137.2M
Follow us
Also headquartered in Geneva
Seedstars World
Seedstars
ProtonMail
World Economic Forum
CERN
Index Ventures
Silent Circle
Temenos
WHO
Fusion
Companies in the same industry
Neurelis
Cambridge Epigenetix
Exco InTouch
JumpStartInc
Imaging3 Inc
Altimmune
Champions Oncology
Advanced Cell Dx
Oxford Nanopore
LifeBond
Alexa global traffic share
